「fo」の検索結果
125件：21～25件目を表示
-
发表论文 | 研究与开发 | 千寿制药株式会社
almology. 2026;283:163-175. VIEW PUBLICATION Cost‑effectiveness Analysis of Ranibizumab Biosimilar for Neovascular Age‑Related Macular Degeneration and its Subtypes from the Societal and Patient Pers...
http://www.senju.co.jp/chinese/rd/thesis/ -
临床试验信息 | 研究与开发 | 千寿制药株式会社
Dry Eye Disease 1/2 SJP-0132 United States Completed NCT04139122 Disclaimer This website provides information on clinical trials sponsored by SENJU PHARMACEUTICAL Co., Ltd. (hereinafter referred to as...
http://www.senju.co.jp/chinese/rd/trial.html -
千寿製薬株式会社
se through TRPV1 Inhibition（PDF） 2025年12月22日 Obtained manufacturing and marketing approval in Japan for Avarept® Ophthalmic suspension 0.3%, a novel treatment of Dry Eye Disease through Transient Rece...
http://www.senju.co.jp/chinese/ -
ealth and prosperity by the realization and synergy of Senju’s mission of the “Pursuit of happiness for all people”, and Rexxam’s` policy the “Take boldly on any challenge, while putting ourselves in ...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240726.pdf -
製品開発方針 | 研究開発活動 | 千寿製薬株式会社
heng CY, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014;2(2):e106-16. #1...
https://www.senju.co.jp/rd/policy/